載入...
Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells
Antibodies targeting the PD-1/PD-L1 immune checkpoint achieved spectacular success in anticancer therapy in the recent years. In contrast, no small molecules with cellular activity have been reported so far. Here we provide evidence that small molecules are capable of alleviating the PD-1/PD-L1 immu...
Na minha lista:
發表在: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Impact Journals LLC
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5641120/ https://ncbi.nlm.nih.gov/pubmed/29069777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20050 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|